TW201529685A - 軟的疏水丙烯酸系材料 - Google Patents
軟的疏水丙烯酸系材料 Download PDFInfo
- Publication number
- TW201529685A TW201529685A TW103142005A TW103142005A TW201529685A TW 201529685 A TW201529685 A TW 201529685A TW 103142005 A TW103142005 A TW 103142005A TW 103142005 A TW103142005 A TW 103142005A TW 201529685 A TW201529685 A TW 201529685A
- Authority
- TW
- Taiwan
- Prior art keywords
- acrylate
- methacrylate
- weight
- acrylic material
- alkyl
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 36
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 230000002209 hydrophobic effect Effects 0.000 title claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 33
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 29
- 239000012530 fluid Substances 0.000 claims abstract description 15
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 11
- -1 diethylene glycol dimethacrylate Ester Chemical class 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 239000006096 absorbing agent Substances 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 14
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 8
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 8
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 7
- XFCMNSHQOZQILR-UHFFFAOYSA-N diethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 claims description 5
- 150000002576 ketones Chemical class 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 4
- 230000032683 aging Effects 0.000 claims description 4
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 claims description 4
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- MNSWITGNWZSAMC-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl prop-2-enoate Chemical compound FC(F)(F)C(C(F)(F)F)OC(=O)C=C MNSWITGNWZSAMC-UHFFFAOYSA-N 0.000 claims description 3
- IJLJDZOLZATUFK-UHFFFAOYSA-N 2,2-dimethylpropyl prop-2-enoate Chemical compound CC(C)(C)COC(=O)C=C IJLJDZOLZATUFK-UHFFFAOYSA-N 0.000 claims description 3
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 claims description 3
- PUXCPQLMEYZWBC-UHFFFAOYSA-N C(C(=C)C)(=O)OC(C(CCCCCCCC(F)(F)F)(F)F)(F)F Chemical compound C(C(=C)C)(=O)OC(C(CCCCCCCC(F)(F)F)(F)F)(F)F PUXCPQLMEYZWBC-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 3
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 claims description 3
- APAUNQLFVGBQQW-UHFFFAOYSA-N (1,2,2-trimethylcyclohexyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1(C)CCCCC1(C)C APAUNQLFVGBQQW-UHFFFAOYSA-N 0.000 claims description 2
- NIJWSVFNELSKMF-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=C(F)C(F)=C(F)C(F)=C1F NIJWSVFNELSKMF-UHFFFAOYSA-N 0.000 claims description 2
- FMQPBWHSNCRVQJ-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C(F)(F)F)C(F)(F)F FMQPBWHSNCRVQJ-UHFFFAOYSA-N 0.000 claims description 2
- GWYSWOQRJGLJPA-UHFFFAOYSA-N 1,1,2,2-tetrafluoropropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(F)(F)C(C)(F)F GWYSWOQRJGLJPA-UHFFFAOYSA-N 0.000 claims description 2
- DEQJNIVTRAWAMD-UHFFFAOYSA-N 1,1,2,4,4,4-hexafluorobutyl prop-2-enoate Chemical compound FC(F)(F)CC(F)C(F)(F)OC(=O)C=C DEQJNIVTRAWAMD-UHFFFAOYSA-N 0.000 claims description 2
- VBHXIMACZBQHPX-UHFFFAOYSA-N 2,2,2-trifluoroethyl prop-2-enoate Chemical compound FC(F)(F)COC(=O)C=C VBHXIMACZBQHPX-UHFFFAOYSA-N 0.000 claims description 2
- VIEHKBXCWMMOOU-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptafluorobutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)C(F)(F)C(F)(F)F VIEHKBXCWMMOOU-UHFFFAOYSA-N 0.000 claims description 2
- PLXOUIVCSUBZIX-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptafluorobutyl prop-2-enoate Chemical compound FC(F)(F)C(F)(F)C(F)(F)COC(=O)C=C PLXOUIVCSUBZIX-UHFFFAOYSA-N 0.000 claims description 2
- YJKHMSPWWGBKTN-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F YJKHMSPWWGBKTN-UHFFFAOYSA-N 0.000 claims description 2
- ZNJXRXXJPIFFAO-UHFFFAOYSA-N 2,2,3,3,4,4,5,5-octafluoropentyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)C(F)(F)C(F)(F)C(F)F ZNJXRXXJPIFFAO-UHFFFAOYSA-N 0.000 claims description 2
- JJBFVQSGPLGDNX-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)COC(=O)C(C)=C JJBFVQSGPLGDNX-UHFFFAOYSA-N 0.000 claims description 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims description 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 claims description 2
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 claims description 2
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 claims description 2
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 claims description 2
- HTWRFCRQSLVESJ-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCOC(=O)C(C)=C HTWRFCRQSLVESJ-UHFFFAOYSA-N 0.000 claims description 2
- ULYIFEQRRINMJQ-UHFFFAOYSA-N 3-methylbutyl 2-methylprop-2-enoate Chemical compound CC(C)CCOC(=O)C(C)=C ULYIFEQRRINMJQ-UHFFFAOYSA-N 0.000 claims description 2
- ZVYGIPWYVVJFRW-UHFFFAOYSA-N 3-methylbutyl prop-2-enoate Chemical compound CC(C)CCOC(=O)C=C ZVYGIPWYVVJFRW-UHFFFAOYSA-N 0.000 claims description 2
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 claims description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 2
- ZWEDFBKLJILTMC-UHFFFAOYSA-N ethyl 4,4,4-trifluoro-3-hydroxybutanoate Chemical compound CCOC(=O)CC(O)C(F)(F)F ZWEDFBKLJILTMC-UHFFFAOYSA-N 0.000 claims description 2
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 claims description 2
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 claims description 2
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 claims description 2
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 claims description 2
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 claims description 2
- GYDSPAVLTMAXHT-UHFFFAOYSA-N pentyl 2-methylprop-2-enoate Chemical compound CCCCCOC(=O)C(C)=C GYDSPAVLTMAXHT-UHFFFAOYSA-N 0.000 claims description 2
- ULDDEWDFUNBUCM-UHFFFAOYSA-N pentyl prop-2-enoate Chemical compound CCCCCOC(=O)C=C ULDDEWDFUNBUCM-UHFFFAOYSA-N 0.000 claims description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 2
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 claims description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 claims description 2
- RRLMGCBZYFFRED-UHFFFAOYSA-N undecyl prop-2-enoate Chemical compound CCCCCCCCCCCOC(=O)C=C RRLMGCBZYFFRED-UHFFFAOYSA-N 0.000 claims description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 2
- 230000006835 compression Effects 0.000 claims 2
- 238000007906 compression Methods 0.000 claims 2
- CLHPBURJMZXHFZ-UHFFFAOYSA-N (1,2,2-trimethylcyclohexyl) prop-2-enoate Chemical compound CC1(C)CCCCC1(C)OC(=O)C=C CLHPBURJMZXHFZ-UHFFFAOYSA-N 0.000 claims 1
- RFOWDPMCXHVGET-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl) prop-2-enoate Chemical compound FC1=C(F)C(F)=C(OC(=O)C=C)C(F)=C1F RFOWDPMCXHVGET-UHFFFAOYSA-N 0.000 claims 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 claims 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
- URFLCXSTNZSALZ-UHFFFAOYSA-N [F].C(C(=C)C)(=O)O Chemical compound [F].C(C(=C)C)(=O)O URFLCXSTNZSALZ-UHFFFAOYSA-N 0.000 claims 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 claims 1
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 abstract description 4
- 238000000034 method Methods 0.000 description 8
- 230000001886 ciliary effect Effects 0.000 description 7
- 125000004494 ethyl ester group Chemical group 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical group C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 4
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 4
- 239000012964 benzotriazole Substances 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000003999 initiator Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000012965 benzophenone Substances 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 201000010041 presbyopia Diseases 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 2
- KRSIODKTBYBKQU-UHFFFAOYSA-N 2-[3-tert-butyl-4-hydroxy-5-(5-methoxybenzotriazol-2-yl)phenoxy]ethyl 2-methylprop-2-enoate Chemical compound N1=C2C=C(OC)C=CC2=NN1C1=CC(OCCOC(=O)C(C)=C)=CC(C(C)(C)C)=C1O KRSIODKTBYBKQU-UHFFFAOYSA-N 0.000 description 2
- HPSGLFKWHYAKSF-UHFFFAOYSA-N 2-phenylethyl prop-2-enoate Chemical compound C=CC(=O)OCCC1=CC=CC=C1 HPSGLFKWHYAKSF-UHFFFAOYSA-N 0.000 description 2
- RLWDBZIHAUEHLO-UHFFFAOYSA-N 3-[3-tert-butyl-5-(5-chlorobenzotriazol-2-yl)-4-hydroxyphenyl]propyl 2-methylprop-2-enoate Chemical compound CC(C)(C)C1=CC(CCCOC(=O)C(=C)C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O RLWDBZIHAUEHLO-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 238000010546 Norrish type I reaction Methods 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003254 radicals Chemical group 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000001043 yellow dye Substances 0.000 description 2
- CJCGDEYGAIPAEN-UHFFFAOYSA-N (1-methylcyclohexyl) prop-2-enoate Chemical compound C=CC(=O)OC1(C)CCCCC1 CJCGDEYGAIPAEN-UHFFFAOYSA-N 0.000 description 1
- RCTZKJGLWRCHMI-UHFFFAOYSA-N (2-ethylphenyl) 2-methylprop-2-eneperoxoate Chemical compound CCC1=CC=CC=C1OOC(=O)C(C)=C RCTZKJGLWRCHMI-UHFFFAOYSA-N 0.000 description 1
- HYZJSTPCAKOIHY-UHFFFAOYSA-N (2-ethylphenyl) prop-2-eneperoxoate Chemical compound CCC1=CC=CC=C1OOC(=O)C=C HYZJSTPCAKOIHY-UHFFFAOYSA-N 0.000 description 1
- SJEBUGJRCJZIRN-UHFFFAOYSA-N (2-fluorophenyl) prop-2-enoate Chemical compound FC1=CC=CC=C1OC(=O)C=C SJEBUGJRCJZIRN-UHFFFAOYSA-N 0.000 description 1
- AOUAMFARIYTDLK-UHFFFAOYSA-N (4-methylphenyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=C(C)C=C1 AOUAMFARIYTDLK-UHFFFAOYSA-N 0.000 description 1
- OJNXPAPLAAGFBJ-UHFFFAOYSA-N (4-methylphenyl) prop-2-enoate Chemical compound CC1=CC=C(OC(=O)C=C)C=C1 OJNXPAPLAAGFBJ-UHFFFAOYSA-N 0.000 description 1
- HEKMZTKFODLXOP-UHFFFAOYSA-N (4-methylphenyl)methyl prop-2-enoate Chemical compound CC1=CC=C(COC(=O)C=C)C=C1 HEKMZTKFODLXOP-UHFFFAOYSA-N 0.000 description 1
- NOBYOEQUFMGXBP-UHFFFAOYSA-N (4-tert-butylcyclohexyl) (4-tert-butylcyclohexyl)oxycarbonyloxy carbonate Chemical compound C1CC(C(C)(C)C)CCC1OC(=O)OOC(=O)OC1CCC(C(C)(C)C)CC1 NOBYOEQUFMGXBP-UHFFFAOYSA-N 0.000 description 1
- LCPUCXXYIYXLJY-UHFFFAOYSA-N 1,1,2,4,4,4-hexafluorobutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(F)(F)C(F)CC(F)(F)F LCPUCXXYIYXLJY-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- MLBWTXHUVGBPNL-UHFFFAOYSA-N 1-pyridin-4-ylheptan-1-one Chemical compound CCCCCCC(=O)C1=CC=NC=C1 MLBWTXHUVGBPNL-UHFFFAOYSA-N 0.000 description 1
- DFVPUWGVOPDJTC-UHFFFAOYSA-N 2,2,3,4,4,4-hexafluorobutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)C(F)C(F)(F)F DFVPUWGVOPDJTC-UHFFFAOYSA-N 0.000 description 1
- PIZHFBODNLEQBL-UHFFFAOYSA-N 2,2-diethoxy-1-phenylethanone Chemical compound CCOC(OCC)C(=O)C1=CC=CC=C1 PIZHFBODNLEQBL-UHFFFAOYSA-N 0.000 description 1
- OOHZIRUJZFRULE-UHFFFAOYSA-N 2,2-dimethylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C)(C)C OOHZIRUJZFRULE-UHFFFAOYSA-N 0.000 description 1
- MYKCFTANKWJWDH-UHFFFAOYSA-N 2-(2-chlorophenyl)ethyl prop-2-enoate Chemical compound ClC1=CC=CC=C1CCOC(=O)C=C MYKCFTANKWJWDH-UHFFFAOYSA-N 0.000 description 1
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 1
- PAVGMLBHCOPIEI-UHFFFAOYSA-N 2-(2-phenylmethoxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCC1=CC=CC=C1 PAVGMLBHCOPIEI-UHFFFAOYSA-N 0.000 description 1
- CAWQOFMAJKVFII-UHFFFAOYSA-N 2-(3-chlorophenyl)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=CC(Cl)=C1 CAWQOFMAJKVFII-UHFFFAOYSA-N 0.000 description 1
- XHDUOAVFFNBVQL-UHFFFAOYSA-N 2-(3-chlorophenyl)ethyl prop-2-enoate Chemical compound ClC1=CC=CC(CCOC(=O)C=C)=C1 XHDUOAVFFNBVQL-UHFFFAOYSA-N 0.000 description 1
- ACZLUEDVQBUFQM-UHFFFAOYSA-N 2-(3-phenylphenyl)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=CC(C=2C=CC=CC=2)=C1 ACZLUEDVQBUFQM-UHFFFAOYSA-N 0.000 description 1
- NTGCKQLQMLLOBM-UHFFFAOYSA-N 2-(3-phenylphenyl)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCC1=CC=CC(C=2C=CC=CC=2)=C1 NTGCKQLQMLLOBM-UHFFFAOYSA-N 0.000 description 1
- XUXKNMQGQVAAJA-UHFFFAOYSA-N 2-(4-benzylphenyl)ethyl 2-methylprop-2-enoate Chemical compound C1=CC(CCOC(=O)C(=C)C)=CC=C1CC1=CC=CC=C1 XUXKNMQGQVAAJA-UHFFFAOYSA-N 0.000 description 1
- XHMBRNYBXTUYJN-UHFFFAOYSA-N 2-(4-bromophenyl)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=C(Br)C=C1 XHMBRNYBXTUYJN-UHFFFAOYSA-N 0.000 description 1
- UBUYTJHCXCSVML-UHFFFAOYSA-N 2-(4-bromophenyl)ethyl prop-2-enoate Chemical compound BrC1=CC=C(CCOC(=O)C=C)C=C1 UBUYTJHCXCSVML-UHFFFAOYSA-N 0.000 description 1
- AOSFJUASIQDDJG-UHFFFAOYSA-N 2-(4-chlorophenyl)ethyl prop-2-enoate Chemical compound ClC1=CC=C(CCOC(=O)C=C)C=C1 AOSFJUASIQDDJG-UHFFFAOYSA-N 0.000 description 1
- WRAODFTZIJZVJH-UHFFFAOYSA-N 2-(4-cyclohexylphenyl)ethyl 2-methylprop-2-enoate Chemical compound C1=CC(CCOC(=O)C(=C)C)=CC=C1C1CCCCC1 WRAODFTZIJZVJH-UHFFFAOYSA-N 0.000 description 1
- IOFBPLNRQQDCSU-UHFFFAOYSA-N 2-(4-methoxyphenyl)ethyl 2-methylprop-2-enoate Chemical compound COC1=CC=C(CCOC(=O)C(C)=C)C=C1 IOFBPLNRQQDCSU-UHFFFAOYSA-N 0.000 description 1
- XKTDLXROKPMKQF-UHFFFAOYSA-N 2-(4-phenylphenyl)ethyl 2-methylprop-2-enoate Chemical compound C1=CC(CCOC(=O)C(=C)C)=CC=C1C1=CC=CC=C1 XKTDLXROKPMKQF-UHFFFAOYSA-N 0.000 description 1
- LQQHDTFYKUFAPF-UHFFFAOYSA-N 2-(4-phenylphenyl)ethyl prop-2-enoate Chemical compound C1=CC(CCOC(=O)C=C)=CC=C1C1=CC=CC=C1 LQQHDTFYKUFAPF-UHFFFAOYSA-N 0.000 description 1
- VZHXURTZSGZTOY-UHFFFAOYSA-N 2-(4-propan-2-ylphenyl)ethyl 2-methylprop-2-enoate Chemical compound CC(C)C1=CC=C(CCOC(=O)C(C)=C)C=C1 VZHXURTZSGZTOY-UHFFFAOYSA-N 0.000 description 1
- BPPOSMLSWFCOHX-UHFFFAOYSA-N 2-(4-propan-2-ylphenyl)ethyl prop-2-enoate Chemical compound CC(C)C1=CC=C(CCOC(=O)C=C)C=C1 BPPOSMLSWFCOHX-UHFFFAOYSA-N 0.000 description 1
- APNXLWNPHUNKTR-UHFFFAOYSA-N 2-(4-propylphenyl)ethyl prop-2-enoate Chemical compound CCCC1=CC=C(CCOC(=O)C=C)C=C1 APNXLWNPHUNKTR-UHFFFAOYSA-N 0.000 description 1
- RBUACGOFWUSJNX-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-ethenylphenol Chemical compound OC1=CC=C(C=C)C=C1N1N=C2C=CC=CC2=N1 RBUACGOFWUSJNX-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- VCYCUECVHJJFIQ-UHFFFAOYSA-N 2-[3-(benzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 VCYCUECVHJJFIQ-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- ILZXXGLGJZQLTR-UHFFFAOYSA-N 2-phenylethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=CC=C1 ILZXXGLGJZQLTR-UHFFFAOYSA-N 0.000 description 1
- CWVFILUMTNJKBN-UHFFFAOYSA-N 2-phenylmethoxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCC1=CC=CC=C1 CWVFILUMTNJKBN-UHFFFAOYSA-N 0.000 description 1
- ROJWTNWAEYEKMO-UHFFFAOYSA-N 2-phenylmethoxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCC1=CC=CC=C1 ROJWTNWAEYEKMO-UHFFFAOYSA-N 0.000 description 1
- RHOOUTWPJJQGSK-UHFFFAOYSA-N 2-phenylsulfanylethyl prop-2-enoate Chemical compound C=CC(=O)OCCSC1=CC=CC=C1 RHOOUTWPJJQGSK-UHFFFAOYSA-N 0.000 description 1
- KARGMXZXPAWXQJ-UHFFFAOYSA-N 3-[3-(benzotriazol-2-yl)-4-hydroxyphenyl]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 KARGMXZXPAWXQJ-UHFFFAOYSA-N 0.000 description 1
- DJENTNKTVLSRNS-UHFFFAOYSA-N 3-phenylmethoxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCOCC1=CC=CC=C1 DJENTNKTVLSRNS-UHFFFAOYSA-N 0.000 description 1
- SJOIDEGZPXSHOC-UHFFFAOYSA-N 3-phenylmethoxypropyl prop-2-enoate Chemical compound C=CC(=O)OCCCOCC1=CC=CC=C1 SJOIDEGZPXSHOC-UHFFFAOYSA-N 0.000 description 1
- RXXZODOCQIRRQA-UHFFFAOYSA-N 3-phenylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCC1=CC=CC=C1 RXXZODOCQIRRQA-UHFFFAOYSA-N 0.000 description 1
- PKBZUGSITIBLFK-UHFFFAOYSA-N 3-phenylpropyl prop-2-enoate Chemical compound C=CC(=O)OCCCC1=CC=CC=C1 PKBZUGSITIBLFK-UHFFFAOYSA-N 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- IGVCHZAHFGFESB-UHFFFAOYSA-N 4-phenylbutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCC1=CC=CC=C1 IGVCHZAHFGFESB-UHFFFAOYSA-N 0.000 description 1
- MXNDNUJKPFXJJX-UHFFFAOYSA-N 4-phenylbutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCC1=CC=CC=C1 MXNDNUJKPFXJJX-UHFFFAOYSA-N 0.000 description 1
- ILGAYROEISMOJM-UHFFFAOYSA-N C(C1=CC=CC=C1)(C1=CC=CC=C1)[PH2]=O Chemical compound C(C1=CC=CC=C1)(C1=CC=CC=C1)[PH2]=O ILGAYROEISMOJM-UHFFFAOYSA-N 0.000 description 1
- HEDCCOWCOJRIMT-UHFFFAOYSA-N C(CC)C=1C(=C(C(=CC1)OC)O)N1N=C2C(=N1)C=CC(=C2)Cl Chemical compound C(CC)C=1C(=C(C(=CC1)OC)O)N1N=C2C(=N1)C=CC(=C2)Cl HEDCCOWCOJRIMT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- CEHDMOILZJBJGZ-UHFFFAOYSA-N OC1=C(C=C(C=C1)OC=CC)N1N=C2C(=N1)C=CC=C2 Chemical compound OC1=C(C=C(C=C1)OC=CC)N1N=C2C(=N1)C=CC=C2 CEHDMOILZJBJGZ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- CXNDOZZRTDUFAP-UHFFFAOYSA-N [2-hydroxy-5-methoxy-3-(5-methoxybenzotriazol-2-yl)phenyl]methyl 2-methylprop-2-enoate Chemical compound N1=C2C=C(OC)C=CC2=NN1C1=CC(OC)=CC(COC(=O)C(C)=C)=C1O CXNDOZZRTDUFAP-UHFFFAOYSA-N 0.000 description 1
- OFQNHOCFIWEGJL-UHFFFAOYSA-N [2-hydroxy-5-methoxy-3-(5-methylbenzotriazol-2-yl)phenyl]methyl 2-methylprop-2-enoate Chemical compound COC1=CC(COC(=O)C(C)=C)=C(O)C(N2N=C3C=C(C)C=CC3=N2)=C1 OFQNHOCFIWEGJL-UHFFFAOYSA-N 0.000 description 1
- ROWSHEZYONOOTN-UHFFFAOYSA-N [2-hydroxy-5-methoxy-3-[5-(trifluoromethyl)benzotriazol-2-yl]phenyl]methyl 2-methylprop-2-enoate Chemical compound COC1=CC(COC(=O)C(C)=C)=C(O)C(N2N=C3C=C(C=CC3=N2)C(F)(F)F)=C1 ROWSHEZYONOOTN-UHFFFAOYSA-N 0.000 description 1
- QYPFCGAMZYCMNM-UHFFFAOYSA-N [2-hydroxy-5-methyl-3-[5-(trifluoromethyl)benzotriazol-2-yl]phenyl]methyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC(C)=CC(N2N=C3C=C(C=CC3=N2)C(F)(F)F)=C1O QYPFCGAMZYCMNM-UHFFFAOYSA-N 0.000 description 1
- CQASBOLQSRQKBZ-UHFFFAOYSA-N [3-(5-chlorobenzotriazol-2-yl)-2-hydroxy-5-methoxyphenyl]methyl 2-methylprop-2-enoate Chemical compound COC1=CC(COC(=O)C(C)=C)=C(O)C(N2N=C3C=C(Cl)C=CC3=N2)=C1 CQASBOLQSRQKBZ-UHFFFAOYSA-N 0.000 description 1
- AQQMDSIQWSFSAE-UHFFFAOYSA-N [3-(benzotriazol-2-yl)-2-hydroxy-5-methoxyphenyl]methyl 2-methylprop-2-enoate Chemical compound COC1=CC(COC(=O)C(C)=C)=C(O)C(N2N=C3C=CC=CC3=N2)=C1 AQQMDSIQWSFSAE-UHFFFAOYSA-N 0.000 description 1
- WIELQWUKLCASNP-UHFFFAOYSA-N [PH3]=O.C(C1=CC=CC=C1)(=N)N Chemical compound [PH3]=O.C(C1=CC=CC=C1)(=N)N WIELQWUKLCASNP-UHFFFAOYSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- CHIHQLCVLOXUJW-UHFFFAOYSA-N benzoic anhydride Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C1=CC=CC=C1 CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- MMCOUVMKNAHQOY-UHFFFAOYSA-N carbonoperoxoic acid Chemical class OOC(O)=O MMCOUVMKNAHQOY-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- HYUPPKVFCGIMDB-UHFFFAOYSA-N ethyl 2-(4-hydroxyphenyl)acetate Chemical compound CCOC(=O)CC1=CC=C(O)C=C1 HYUPPKVFCGIMDB-UHFFFAOYSA-N 0.000 description 1
- 239000012632 extractable Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KVILQFSLJDTWPU-UHFFFAOYSA-N heptadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCOC(=O)C=C KVILQFSLJDTWPU-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- DOULWWSSZVEPIN-UHFFFAOYSA-N isoproturon-monodemethyl Chemical compound CNC(=O)NC1=CC=C(C(C)C)C=C1 DOULWWSSZVEPIN-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- QIWKUEJZZCOPFV-UHFFFAOYSA-N phenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1 QIWKUEJZZCOPFV-UHFFFAOYSA-N 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
- C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
- C08F220/1804—C4-(meth)acrylate, e.g. butyl (meth)acrylate, isobutyl (meth)acrylate or tert-butyl (meth)acrylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/22—Esters containing halogen
- C08F220/24—Esters containing halogen containing perhaloalkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
- C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
- C08F222/102—Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Transplantation (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Prostheses (AREA)
Abstract
揭露具有改良之抗流體擴散性及適合機械性質而能於施力時變形之軟的疏水丙烯酸系材料。此丙烯酸系材料係特別適用於以流體為主之調節式人工晶體,且包含一經全氟取代之烷基(甲基)丙烯酸酯及一(甲基)丙烯酸烷酯,及一交聯劑之組合。
Description
本發明一般係有關於具有改良之抗流體擴散性及適合機械性質而能於施力時變形之軟的疏水丙烯酸系材料,其係合意地作為用於以流體為主之調節式人工晶體(IOL)之生物可相容材料。
人類眼睛以其最簡單術語係用於藉由經一稱為眼角膜之透明外部份透射光線且藉由一晶狀體使影像聚焦於一視網膜上而提供視覺。經聚焦之影像的品質係依許多因素而定,包含眼睛之尺寸及形狀,及眼角膜及晶狀體之透明度。
於自然晶狀體,遠距及近距視覺之雙聚焦係藉由一稱為調節之機構提供。自然晶狀體係包含於囊袋內且於生命早期係軟的。囊袋係藉由小帶自睫狀肌懸置。睫狀肌鬆弛使小帶變緊,並且拉伸囊袋。因此,自然晶狀體易平坦化。睫狀肌變緊使小帶上的張力鬆弛,使囊袋及自然晶狀體呈現較圓形狀。以此方式,自然晶狀體可交替聚焦於近及遠的物件上。
當晶狀體老化,其變得較硬且對睫狀肌變緊的反
應較不能改變其形狀。此較難使晶狀體聚焦於近物件上,稱為老花眼之醫學狀況。老花眼影響幾乎所有超過45或50年齡之成人。
當年齡或疾病造成晶狀體變得較不透明,視覺因為可傳送至視網膜的光線減少而惡化。眼睛晶狀體之此缺陷醫學上稱為白內障。對於此狀況之一被接受的治療係手術移除晶狀體及以一人工晶體(IOL)替代晶狀體功能。
在美國,大部份之白內障晶狀體係藉由稱為晶狀體乳化術之一手術技術移除。於此程序期間,於前囊層產生一開口,且一薄的晶狀體乳化術切割尖端插入患病之晶狀體內且以超音波振動。振動之切割尖端使晶狀體液化或乳化,使得晶狀體可自眼睛吸出。患病之晶狀體一旦被移除,其係以一人工晶狀體替代。傳統IOL之植入會使白內障患者之視覺恢復,但不能減輕老花眼。
廣泛研究努力已促成發展出調節式IOL,其回應睫狀肌收縮具有如同自然晶狀體般改變其光功率之能力。調節式IOL之積極研究領域之一係以流體為主之調節式IOL,其於睫狀肌收縮/鬆弛時能進行曲率改變(例如,美國專利第4,787,903、4,816,031、4,932,966、5,066,301、5,443,506、6,117,171、6,730,123、7,122,053、7,217,288、7,247,168、7,261,737、7,438,723、7,485,144、7,753,953、7,776,088、8,038,711、8,048,155、8,158,712、8,197,541、8,361,145、8,398,709、8,454,688、8,475,529號案,及美國專利申請案公開第2013/02668070 A1號案,其等在此被完整
併入以供參考)。US 8,158,712描述生物可相容聚合物,其包含甲基丙烯酸三氟乙酯(或其替代物)、丙烯酸丁酯(或其替代物),及乙基丙烯酸苯酯(或其替代物),且具有約0.1MPa與約0.6MPa間之彈性模數及約1.44與約1.52間之折射率,且對於流體(諸如,矽酮油、水,或鹽水)之擴散係實質上具抗性。依據US 8,158,712,該等生物可相容之聚合物可用於製造調節式IOL,其包含一可變形光學前表面及軟的可變形觸覺介面,其依賴以可變形光學前表面之形狀的流體傳動變化。
已發現軟的疏水丙烯酸系材料,其係特別適於作為以流體為主之調節式IOL,但其亦可作為其它眼部或耳鼻喉部之裝置,諸如,隱形眼鏡、人工角膜、角膜環或鑲嵌物、耳部通風管及鼻植入物。此等聚合物材料包含一全氟丙烯酸系單體及一烴丙烯酸系單體之一選擇組合。
於其它因素中,本發明係以發現全氟丙烯酸系單體及烴丙烯酸系單體之適當組合造成軟的疏水材料為基礎,此材料顯示合意機械性質(例如,從約1MPa至約3MPa之貯存模數)及於高折射率矽酮油加速老化後極低之矽酮吸取。此主題材料係特別適於製造以流體為主之調節式IOL。
除了其它定義外,此處使用之所有科技及科學術語具有與熟習本發明所屬技藝者普遍瞭解之相同意義。一般,此處使用之命名及實驗室程序係此項技藝所熟知及普遍使用。傳統方法被用於此等程序,諸如,於此技藝及各種一般參考資料中提供者。若一術語係以單數提供,發明人亦考慮到此術語之複數。以下描述之於此處使用之命名法及實驗室程序係此項技藝所熟知及普遍使用。
"約"於此處使用時係意指以"約"提及之一數量係包含述及之數量加上或減去此述及數量之1-10%。
“選擇性”或“選擇性地”意指其會描述之事件或情況會或不會發生,且此描述包含此事件或情況發生之實例及不會發生之實例。
除了其它指示外,所有組份量係以%(w/w)重量("wt.%")表示。
術語“烷基”係指藉由自一線性或分支之烷化合物移除一氫原子而獲得之一單價基團。一烷基基團(基)與一有機化合物中之一其它基團形成一鍵結。
術語“經全氟取代之烷基”係指包含至少三個氟原子且其等之每一者係替代烷基之一氫原子之一烷基基團。
術語“伸烷基二價基”或“伸烷基二基團”或“烷基
二基團”交替地係指藉由自一烷基移除一氫原子而獲得之一二價基團。一伸烷基二價基團與一有機化合物中之其它基團形成二鍵結。
術語“烷氧”或“烷氧基”係指藉由自一線性或分支之烷醇之羥基基團移除氫原子而獲得之一單價基團。一烷氧基團(基)與一有機化合物之一其它基團形成一鍵結。
於此申請案,關於一烷基二基團或一烷基基團之術語“經取代”意指此烷基二基團或烷基基團包含至少一取代基,其替代烷基二基團或烷基基團之一氫原子,且係選自由羥基(-OH)、羧基(-COOH)、-NH2、硫氫基(-SH)、C1-C4烷基、C1-C4烷氧基、C1-C4烷硫基(烷基硫化物)、C1-C4醯基胺基、C1-C4烷基胺基、二-C1-C4烷基胺基、鹵素原子(Br或Cl),及其等之組合所組成之群組。
術語“(甲基)丙烯酸酯”係指含有-O-C(=O)-CH=CH2或-O-C(=O)-C(CH3)=CH2之基團的一單體。
術語“芳基丙烯酸系單體”係指具有下列化學式之一單體
其中:A係H或CH3;B2係(CH2)m或[O(CH2)2]Z;m係2-6;z係1-10;Y係一直接鍵、O、S,或NR',只要若Y係O、S,或NR',則B係(CH2)m;R'係H、CH3、Cn'H2n'+1、異-OC3H7、C6H5,或CH2C6H5;n'=1-10;w係0-6只要m+w8;且D係H、
Cl、Br、C1-C4烷基、C1-C4烷氧基、C6H5,或CH2C6H5。芳基丙烯酸系單體之例子不受限地包含:丙烯酸2-乙基苯氧酯;甲基丙烯酸2-乙基苯氧酯;丙烯酸苯酯;甲基丙烯酸苯酯;丙烯酸苯甲酯;甲基丙烯酸苯甲酯;丙烯酸2-苯基乙酯;甲基丙烯酸2-苯基乙酯;丙烯酸3-苯基丙酯;甲基丙烯酸3-苯基丙酯;丙烯酸4-苯基丁酯;甲基丙烯酸4-苯基丁酯;丙烯酸4-甲基苯酯;甲基丙烯酸4-甲基苯酯;丙烯酸4-甲基苯甲酯;甲基丙烯酸4-甲基苯甲酯;丙烯酸2-2-甲基苯基乙酯;甲基丙烯酸2,2-甲基苯基乙酯;丙烯酸2,3-甲基苯基乙酯;甲基丙烯酸2,3-甲基苯基乙酯;丙烯酸2,4-甲基苯基乙酯;甲基丙烯酸2,4-甲基苯基乙酯;丙烯酸2-(4-丙基苯基)乙酯;甲基丙烯酸2-(4-丙基苯基)乙酯;丙烯酸2-(4-(1-甲基乙基)苯基)乙酯;甲基丙烯酸2-(4-(1-甲基乙基)苯基)乙酯;丙烯酸2-(4-甲氧基苯基)乙酯;甲基丙烯酸2-(4-甲氧基苯基)乙酯;丙烯酸2-(4-環己基苯基)乙酯;甲基丙烯酸2-(4-環己基苯基)乙酯;丙烯酸2-(2-氯苯基)乙酯;甲基丙烯酸2-(2-氯苯基)乙酯;丙烯酸2-(3-氯苯基)乙酯;甲基丙烯酸2-(3-氯苯基)乙酯;丙烯酸2-(4-氯苯基)乙酯;甲基丙烯酸2-(4-氯苯基)乙酯;丙烯酸2-(4-溴苯基)乙酯;甲基丙烯酸2-(4-溴苯基)乙酯;丙烯酸2-(3-苯基苯基)乙酯;甲基丙烯酸2-(3-苯基苯基)乙酯;丙烯酸2-(4-苯基苯基)乙酯;甲基丙烯酸2-(4-苯基苯基)乙酯;丙烯酸2-(4-苯甲基苯基)乙酯;甲基丙烯酸2-(4-苯甲基苯基)乙酯;丙烯酸2-(苯硫基)乙酯;甲基丙烯酸2-(苯硫基)乙酯;丙烯酸2-苯甲氧基乙
酯;丙烯酸3-苯甲氧基丙酯;甲基丙烯酸2-苯甲氧基乙酯;甲基丙烯酸3-苯甲氧基丙酯;丙烯酸2-[2-(苯甲氧基)乙氧基]乙酯;甲基丙烯酸2-[2-(苯甲氧基)乙氧基]乙酯;或其等之組合。
一般,本發明係有關於軟的疏水丙烯酸系材料,其具有改良之抗流體擴散性及適合機械性質而能於施力時變形。本發明之一軟的疏水丙烯酸系材料特徵在於具有從約0.5MPa至約3.0MPa(較佳係從約0.75MPa至約2.5MPa,更佳係從約1.0MPa至約2.0MPa)之貯存模數,其係於約35℃於壓縮模式下藉由動力機械分析(DMA)測量,及於70℃於一矽酮流體中加速老化32天後少於約2.0重量%(較佳係少於約1.5重量%,更佳係少於約1.0重量%或更少,更佳係約0.8重量%或更少,最佳係約0.5重量%或更少)之矽酮吸取,且係自一可聚合組成物獲得,此可聚合組成物包含從約55重量%至約90重量%(較佳係從約60重量%至約85重量%,更佳係從約65重量%至約80重量%)之至少一經全氟取代之C2-C12烷基(甲基)丙烯酸酯(C2-C12 alkyl(meth)acrylate);從約10重量%至約45重量%(較佳係從約15重量%至約40重量%,更佳係從約20重量%至約35重量%)之至少一C2-C12烷基(甲基)丙烯酸酯(C2-C12 alkyl(meth)acrylate);及至少一交聯劑,但有條件是,此可聚合組成物係實質上無(即,少於約2重量%,較佳係少於約1重量%,更佳係約0.5重量%或更少,更佳係約0.1重量%或更少,最佳係完全無)任何芳基丙烯酸系單體。
任何適合之C2-C12烷基(甲基)丙烯酸酯可用於本發明。較佳C2-C12烷基(甲基)丙烯酸酯之例子不受限地包含丙烯酸乙酯、甲基丙烯酸乙酯、丙烯酸正丙酯、甲基丙烯酸正丙酯、丙烯酸正丁酯、甲基丙烯酸正丁酯、丙烯酸正戊酯、甲基丙烯酸正戊酯、丙烯酸正己酯、甲基丙烯酸正己酯、丙烯酸正庚酯、甲基丙烯酸正庚酯、丙烯酸正辛酯、甲基丙烯酸正辛酯、丙烯酸正壬酯、甲基丙烯酸正壬酯、丙烯酸正癸酯、甲基丙烯酸正癸酯、丙烯酸正十一烷酯、甲基丙烯酸正十一烷酯、丙烯酸十二烷酯、甲基丙烯酸十二烷酯、丙烯酸2-乙基己酯、甲基丙烯酸2-乙基己酯、丙烯酸2,2-二甲基丙酯、甲基丙烯酸2,2-二甲基丙酯、丙烯酸三甲基環己酯、甲基丙烯酸三甲基環己酯、丙烯酸異丁酯、甲基丙烯酸異丁酯、丙烯酸異戊酯、甲基丙烯酸異戊酯,及此等之混合物。
任何適合之經全氟取代之C2-C12烷基(甲基)丙烯酸酯可用於本發明。經全氟取代之C2-C12烷基(甲基)丙烯酸酯之例子不受限地包含甲基丙烯酸2,2,2-三氟乙酯、丙烯酸2,2,2-三氟乙酯、甲基丙烯酸四氟丙酯、丙烯酸四氟丙酯、甲基丙烯酸六氟異丙酯、丙烯酸六氟異丙酯、甲基丙烯酸六氟丁酯、丙烯酸六氟丁酯、甲基丙烯酸七氟丁酯、丙烯酸七氟丁酯、甲基丙烯酸八氟戊酯、丙烯酸八氟戊酯、甲基丙烯酸十二氟庚酯、丙烯酸十七氟癸酯、甲基丙烯酸十七氟癸酯、丙烯酸五氟苯酯、甲基丙烯酸五氟苯酯,及此等之組合。
交聯劑可為具有多於一個不飽和基團之任何末端乙烯不飽和化合物。適合交聯劑包含,例如:乙二醇二甲基丙烯酸酯;二乙二醇二甲基丙烯酸酯;三乙二醇二甲基丙烯酸酯、四乙二醇二甲基丙烯酸酯、甲基丙烯酸烯丙酯;1,3-丙二醇二甲基丙烯酸酯;2,3-丙二醇二甲基丙烯酸酯;1,6-己二醇二甲基丙烯酸酯;1,4-丁二醇二甲基丙烯酸酯;CH2=C(CH3)C(=O)O-(CH2CH2O)p-C(=O)C(CH3)=CH2,其中,p=1-50;及CH2=C(CH3)C(=O)O(CH2)tO-C(=O)C(CH3)=CH2,其中,t=3-20;其等之相對應丙烯酸酯;及其等之組合。一較佳交聯單體係CH2=C(CH3)C(=O)O-(CH2CH2O)p-C(=O)C-(CH3)=CH2,其中,p係使得數平均分子量係約400、約600,或約1000。其它較佳交聯單體係乙二醇二甲基丙烯酸酯(EGDMA)、二乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、三乙二醇二丙烯酸酯,及1,4-丁二醇二丙烯酸酯(BDDA)。
一般,交聯組份之總量係至少0.1重量%,且依剩餘組份之特性及濃度及丙烯酸系材料之期望物理性質而定,範圍可最高達約20重量%。交聯組份之較佳濃度範圍對於具有典型上少於500道爾頓(Dalton)之分子量的小化合物係1-5%,且對於較大化合物(具有典型上大於500道爾頓之分子量)係5-17%(w/w)。
除一或多種經全氟取代之C2-C12(甲基)丙烯酸酯、一或多種C2-C12烷基(甲基)丙烯酸酯,及一或多種交聯劑外,本發明之丙烯酸系材料亦可含有其它成份,不受限
地包含可聚合之UV吸收劑(或UV吸收試劑)、可聚合之經著色的染料、降低黏性之添加劑,及此等之組合。
一可聚合之紫外線(UV)吸收劑亦可被包含於本發明之材料內。可聚合之UV吸收劑可為吸收紫外線(即,具有短於約380nm之波長的光)及選擇性之高能紫外線(HEVL)(即,具有380nm與440nm間之波長的光),但不能吸收任何大量之具有大於440nm之波長的可見光之任何化合物。UV吸收化合物被併納於單體混合物中,且當單體混合物被聚合時陷入聚合物基質中。任何適合之可聚合之UV吸收劑可用於本發明。用於本發明之一可聚合之UV吸收劑包含一二苯甲酮部份或較佳係一苯并三唑部份。可聚合之含二苯甲酮之UV吸收劑可依據於美國專利第3,162,676及4,304,895號案(在此被完整併入其供參考)中所述之程序製備,或可自商業供應商獲得。可聚合之含苯并三唑之UV吸收劑可依據於美國專利第3,299,173、4,612,358、4,716,234、4,528,311、8,153,703,及US 8,232,326號案(在此被完整併入以供參考)中所述之程序製備,或可自商業供應商獲得。
較佳之可聚合之含二苯甲酮之UV吸收劑的例子不受限地包含2-羥基-4-丙烯醯氧基烷氧基二苯甲酮、2-羥基-4-甲基丙烯醯氧基烷氧基二苯甲酮、烯丙基-2-羥基二苯甲酮、4-丙烯醯基乙氧基-2-羥基二苯甲酮(UV2)、2-羥基-4-甲基丙烯醯基氧基二苯甲酮(UV7),或此等之組合。
較佳之可聚合之含苯并三唑之UV吸收劑及UV/HEVL吸收劑的例子不受限地包含:2-(2-羥基-5-乙烯基
苯基)-2H-苯并三唑、2-(2-羥基-5-丙烯醯氧基苯基)-2H-苯并三唑、2-(2-羥基-3-甲基丙烯基醯胺基甲基-5-第三辛基苯基)苯并三唑、2-(2'-羥基-5'-甲基丙烯基醯胺基苯基)-5-氯苯并三唑、2-(2'-羥基-5'-甲基丙烯基醯胺基苯基)-5-甲氧基苯并三唑、2-(2'-羥基-5'-甲基丙烯醯氧基丙基-3'-第三丁基-苯基)-5-氯苯并三唑、2-(2'-羥基-5'-甲基丙烯醯氧基丙基苯基)苯并三唑、2-羥基-5-甲氧基-3-(5-(三氟甲基)-2H-苯并[d][1,2,3]三唑-2-基)苯甲基甲基丙烯酸酯(WL-1)、2-羥基-5-甲氧基-3-(5-甲氧基-2H-苯并[d][1,2,3]三唑-2-基)苯甲基甲基丙烯酸酯(WL-5)、3-(5-氟-2H-苯并[d][1,2,3]三唑-2-基)-2-羥基-5-甲氧基苯甲基甲基丙烯酸酯(WL-2)、3-(2H-苯并[d][1,2,3]三唑-2-基)-2-羥基-5-甲氧基苯甲基甲基丙烯酸酯(WL-3)、3-(5-氯-2H-苯并[d][1,2,3]三唑-2-基)-2-羥基-5-甲氧基苯甲基甲基丙烯酸酯(WL-4)、2-羥基-5-甲氧基-3-(5-甲基-2H-苯并[d][1,2,3]三唑-2-基)苯甲基甲基丙烯酸酯(WL-6)、2-羥基-5-甲基-3-(5-(三氟甲基)-2H-苯并[d][1,2,3]三唑-2-基)苯甲基甲基丙烯酸酯(WL-7)、4-烯丙基-2-(5-氯-2H-苯并[d][1,2,3]三唑-2-基)-6-甲氧基酚(WL-8)、2-{2’-羥基-3’-第三-5’[3”-(4”-乙烯基苯甲氧基)丙氧基]苯基}-5-甲氧基-2H-苯并三唑、酚,2-(5-氯-2H-苯并三唑-2-基)-6-(1,1-二甲基乙基)-4-乙烯基-(UVAM)、2-(2'-羥基-5'-甲基丙烯醯氧基乙基苯基)苯并三唑(2-丙烯酸,2-甲基-,2-[3-(2H-苯并三唑-2-基)-4-羥基苯基]乙酯,Norbloc)、2-{2’-羥基-3’-第三丁基-5’-[3’-甲基丙烯醯基氧丙氧基]苯基}-5-甲氧基-2H-
苯并三唑(UV13)、2-[2’-羥基-3’-第三丁基-5’-(3’-丙烯氧基氧丙氧基)苯基]-5-三氟甲基-2H-苯并三唑(CF3-UV13)、2-(2’-羥基-5-甲基丙烯基醯胺基苯基)-5-甲氧基苯并三唑(UV6)、2-(3-烯丙基-2-羥基-5-甲基苯基)-2H-苯并三唑(UV9)、2-(2-羥基-3-甲基烯丙基-5-甲基苯基)-2H-苯并三唑(UV12)、2-3’-第三丁基-2’-羥基-5’-(3”-二甲基乙烯基矽烷基丙氧基)-2’-羥基-苯基)-5-甲氧基苯并三唑(UV15)、2-(2,-羥基-5’-甲基丙烯醯基丙基-3’-第三丁基-苯基)-5-甲氧基-2H-苯并三唑(UV16)、2-(2’-羥基-5’-丙烯醯基丙基-3’-第三丁基-苯基)-5-甲氧基-2H-苯并三唑(UV16A)、2-甲基丙烯酸3-[3-第三丁基-5-(5-氯苯并三唑-2-基)-4-羥基苯基]-丙酯(16-100,CAS#96478-15-8)、2-(3-(第三丁基)-4-羥基-5-(5-甲氧基-2H-苯并[d][1,2,3]三唑-2-基)苯氧基)乙基甲基丙烯酸酯(16-102);酚,2-(5-氯-2H-苯并三唑-2-基)-6-甲氧基-4-(2-丙烯-1-基)(CAS#1260141-20-5);2-[2-羥基-5-[3-(甲基丙烯醯基氧)丙基]-3-第三丁基苯基]-5-氯-2H-苯并三唑;酚,2-(5-乙烯基-2H-苯并三唑-2-基)-4-甲基-,均聚物(9CI)(CAS#83063-87-0)。
更佳地,一可聚合之UV吸收劑係2-(2H-苯并[d][1,2,3]三唑-2-基)-4-甲基-6-(2-甲基烯丙基)酚(oNTP)、3-[3-第三丁基-4-羥基-5-(5-甲氧基-2-苯并[d][1,2,3]三唑-2-基)苯氧基]丙基甲基丙烯酸酯(UV13),及2-[3-(2H-苯并三唑-2-基)-4-羥基苯基]乙基甲基丙烯酸酯(Norbloc 7966),或此等之組合。
除紫外線性吸收材料外,本發明之丙烯酸系材料可包含經著色的染料,諸如,於美國專利第5,470,932號案中揭露之黃色染料。
本發明之裝置材料亦可含有降低或去除黏性之添加劑。此等添加劑之例子包含於美國專利第7,585,900及7,714,039號案中揭露者,此等案之全部內容在此被併入以供參考。
於一更佳實施例,本發明之丙烯酸系材料包含甲基丙烯酸十七氟癸酯作為經全氟取代之C2-C12烷基(甲基)丙烯酸酯,丙烯酸丁酯作為C2-C12烷基(甲基)丙烯酸酯,及乙二醇二甲基丙烯酸酯作為交聯劑。
本發明之丙烯酸系材料係藉由傳統聚合反應方法製備。例如,為期望比例之一經全氟取代之C2-C12烷基(甲基)丙烯酸酯、一C2-C12烷基(甲基)丙烯酸酯、一交聯劑,及一自由基起始劑,及與任何其它可聚合組份(諸如,一可聚合之UV吸收劑、可聚合之黃色染料,及/或降低黏性之添加劑)一起之一混合物被製備。然後,此混合物可被引至具期望形狀之一模具內,且聚合反應以熱(即,藉由加熱)或光化學(即,藉由光化輻射,例如,UV輻射及/或可見光輻射)活化起始劑而實行。
適合之熱起始劑的例子不受限地包含:偶氮腈類,諸如,2,2'-偶氮雙(2,4-二甲基戊腈)、2,2'-偶氮雙(2-甲基丙腈)、2,2'-偶氮雙(2-甲基丁腈)、2,2’-偶氮雙(異丁腈)(AIBN);過氧化物類,諸如,過氧化苯甲醯;過氧碳酸
酯類,諸如,雙-(4-第三丁基環己基)過氧二碳酸酯等。一較佳起始劑係AIBN。
若聚合反應係光化學進行,一模具係對具有能起始聚合反應之波長的光化輻射係透明。傳統光起始劑化合物,例如,二苯甲酮型或雙醯基膦氧化物(BAPO)光起始劑,亦可被引入以增強聚合反應。適合之光起始劑係安息香甲基醚、二乙氧基苯乙酮、苯甲醯基膦氧化物、1-羥基環己基苯基酮、Darocur及Irgacur型之光起始劑(較佳係Darocur 1173®、Darocur 2959®及Irgacure 819®),及以鍺烷為主之Norrish I型光起始劑,其能於以含有約400至約550nm之區域的光線之一光源照射下能起始一自由基聚合反應。苯甲醯基膦氧化物之例子包含2,4,6-三甲基苯甲醯基二苯基膦氧化物;雙-(2,6-二氯苯甲醯基)-4-N-丙基苯基膦氧化物;及雙-(2,6-二氯苯甲醯基)-4-N-丁基苯基膦氧化物。以鍺烷為主之Norrish I型光起始劑之例子係於US 7,605,190(在此被完整併入以供參考)中所述之醯基鍺化合物。
無論選擇之起始劑或固化方法,固化方法需受控制以避免快速聚合反應,此會產生具有比較慢聚合之相同材料更多黏性之經聚合的材料。
一旦本發明之丙烯酸系材料已固化,其等於一適合溶劑中萃取以移除儘可能多的此材料之未反應性組份。適合溶劑之例子包含丙酮、甲醇,及環己烷。用於萃取之一較佳溶劑係丙酮。
由所揭露之丙烯酸系材料建構成之以流體為主之調節式IOL可具有於對睫狀肌收縮之反應能如自然晶狀體設改變光功率之任何設計。此等調節式IOL之例子不受限地包含於US 8361145、US 8254034、US 8034106,及US 6730123(在此被完整併入以供參考)中所述者。
除了IOL外,本發明之丙烯酸系材料亦適用於其它裝置,包含隱形眼鏡、人工角膜、角膜內鏡片、角膜環或鑲嵌物,及青光眼過濾裝置。
先前之揭露能使熟習此項技藝者實施本發明。為使讀者更能瞭解其特別實施例及優點,建議參考下列非限制性範例。但是,下列範例不應被作為限制本發明而閱讀。
調配組份係顯示於表1及表2中。測量厚度為0.9mm之測試樣品係藉由使填充調配物之模具於一填充氮氣之手套箱中於55℃預熱10分鐘,然後,以一Philips TLK 40W/03 24-英吋螢光燈照射60分鐘而光固化。經固化之樣品於丙酮中連續萃取3天,然後,於環境溫度緩慢乾燥20小時,其後於70℃真空(0.1mm Hg)最少20小時。然後,每一樣品的重量被記錄,且每一樣品被置於含有5.0克之聚(苯基甲基矽氧烷)[Mn:~2600,無低分子量分餾物(<1000))]之一5毫升玻璃小瓶內。步驟被進行以確保樣品完全浸沒於液體中。然後,玻璃小瓶以PTFE塗面丁基膠塞密封,且置於一70℃對流烤箱內。樣品於預定時間間隔自烤箱移除,以Kimwipes小心擦拭以移除表面上之殘餘矽酮流體,並且稱
重。
BA=丙烯酸正丁酯
TFEMA=甲基丙烯酸2,2,2-三氟乙酯
PEA=丙烯酸2-苯基乙酯
HFIPA=丙烯酸1,1,1,3,3,3-六氟異丙酯
HFBMA=甲基丙烯酸2,2,3,3,4,4,4-七氟丁酯
EGDMA=乙二醇二甲基丙烯酸酯
Irgacure 819=苯基雙(2,4,6-三甲基苯甲醯基)膦氧化物
HFMA=甲基丙烯酸1H,1H,2H,2H-十七氟癸酯
可萃取物重量百分率、機械性質,及矽酮吸取重量百分率係顯示於表3。
Claims (10)
- 一種軟的疏水丙烯酸系材料,特徵在於具有從約0.5MPa至約3.0MPa之貯存模數,其係於約35℃於壓縮模式下藉由動力機械分析測量,及於70℃於一矽酮流體中加速老化32天後少於約2.0重量%之矽酮吸取,其中,該丙烯酸系材料係自一可聚合組成物獲得,該可聚合組成物包含:a)從約55重量%至約90重量%之至少一經全氟取代之C2-C12烷基(甲基)丙烯酸酯;b)從約10重量%至約45重量%之至少一C2-C12烷基(甲基)丙烯酸酯;及c)至少一交聯劑,但有條件是,該可聚合組成物係實質上無(即,少於約2重量%)任何芳基丙烯酸系單體。
- 如請求項1之丙烯酸系材料,其中,該丙烯酸系材料特徵在於具有從約0.75MPa至約2.5MPa之貯存模數,其係於約35℃於壓縮模式下藉由動力機械分析測量,及於70℃於一矽酮流體中加速老化32天後少於約1.50重量%之矽酮吸取。
- 如請求項1或2之丙烯酸系材料,其中,該可聚合組成物包含:a)從約60重量%至約85重量%之至少一經全氟取代之C2-C12烷基(甲基)丙烯酸酯; b)從約15重量%至約40重量%之至少一C2-C12烷基(甲基)丙烯酸酯;c)一交聯劑,但有條件是,該可聚合組成物係少於約1重量%之任何芳基丙烯酸系單體。
- 如請求項1至3中任一項之丙烯酸系材料,其中,該至少一經全氟取代之C2-C12烷基(甲基)丙烯酸酯係選自由甲基丙烯酸2,2,2-三氟乙酯、丙烯酸2,2,2-三氟乙酯、甲基丙烯酸四氟丙酯、丙烯酸四氟丙酯、甲基丙烯酸六氟異丙酯、丙烯酸六氟異丙酯、甲基丙烯酸六氟丁酯、丙烯酸六氟丁酯、甲基丙烯酸七氟丁酯、丙烯酸七氟丁酯、甲基丙烯酸八氟戊酯、丙烯酸八氟戊酯、甲基丙烯酸十二氟庚酯、丙烯酸十七氟癸酯、甲基丙烯酸十七氟癸酯、丙烯酸五氟苯酯、甲基丙烯酸五氟苯酯,及此等之組合所組成之群組。
- 如請求項1至4中任一項之丙烯酸系材料,其中,該至少一C2-C12烷基(甲基)丙烯酸酯係選自由丙烯酸乙酯、甲基丙烯酸乙酯、丙烯酸正丙酯、甲基丙烯酸正丙酯、丙烯酸正丁酯、甲基丙烯酸正丁酯、丙烯酸正戊酯、甲基丙烯酸正戊酯、丙烯酸正己酯、甲基丙烯酸正己酯、丙烯酸正庚酯、甲基丙烯酸正庚酯、丙烯酸正辛酯、甲基丙烯酸正辛酯、丙烯酸正壬酯、甲基丙烯酸正壬酯、丙烯酸正癸酯、甲基丙烯酸正癸酯、丙烯酸正十一烷酯、甲基丙烯酸正十一烷酯、丙烯酸十二烷酯、甲基丙烯酸十二烷酯、丙烯酸2-乙基己酯、甲基丙烯酸2-乙基己酯、 丙烯酸2,2-二甲基丙酯、甲基丙烯酸2,2-二甲基丙酯、丙烯酸三甲基環己酯、甲基丙烯酸三甲基環己酯、丙烯酸異丁酯、甲基丙烯酸異丁酯、丙烯酸異戊酯、甲基丙烯酸異戊酯,及此等之混合物所組成之群組。
- 如請求項1至5中任一項之丙烯酸系材料,其中,該至少一交聯劑係選自由下列所組成之群組:乙二醇二甲基丙烯酸酯;二乙二醇二甲基丙烯酸酯;三乙二醇二甲基丙烯酸酯、四乙二醇二甲基丙烯酸酯、甲基丙烯酸烯丙酯;1,3-丙二醇二甲基丙烯酸酯;2,3-丙二醇二甲基丙烯酸酯;1,6-己二醇二甲基丙烯酸酯;1,4-丁二醇二甲基丙 烯酸酯;,其中,p=1-50;及 ,其中,t=3-20;其等之相對應 丙烯酸酯;及其等之組合。
- 如請求項1至6中任一項之丙烯酸系材料,其中,於該可聚合組成物中之該至少一交聯劑之量,若該交聯劑之分子量少於500道爾頓(Dalton),係1-5%,或若該交聯劑之該分子量大於500道爾頓,係5-17%。
- 如請求項1至7中任一項之丙烯酸系材料,其中,該可聚合組成物進一步包含一或多種選自由下列所組成群組之可聚合組份:一可聚合之UV吸收劑、一可聚合之經著色的染料、一矽氧烷單體,及此等之組合。
- 如請求項1至8中任一項之丙烯酸系材料,其中,該可聚 合組成物包含甲基丙烯酸十七氟癸酯、丙烯酸丁酯,及乙二醇二甲基丙烯酸酯。
- 一種調節式人工晶體,包含如請求項1至9中任一項之一軟的疏水丙烯酸系材料。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361911549P | 2013-12-04 | 2013-12-04 | |
| US61/911,549 | 2013-12-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201529685A true TW201529685A (zh) | 2015-08-01 |
| TWI639644B TWI639644B (zh) | 2018-11-01 |
Family
ID=52134414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW103142005A TWI639644B (zh) | 2013-12-04 | 2014-12-03 | 軟的疏水丙烯酸系材料 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10722612B2 (zh) |
| EP (1) | EP3077429B1 (zh) |
| JP (1) | JP6224837B2 (zh) |
| CN (1) | CN105793303B (zh) |
| AR (1) | AR098601A1 (zh) |
| AU (1) | AU2014357332B2 (zh) |
| CA (1) | CA2927620C (zh) |
| DK (1) | DK3077429T3 (zh) |
| ES (1) | ES2699994T3 (zh) |
| PL (1) | PL3077429T3 (zh) |
| PT (1) | PT3077429T (zh) |
| TW (1) | TWI639644B (zh) |
| WO (1) | WO2015084786A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016534816A (ja) | 2013-11-01 | 2016-11-10 | レンスゲン、インコーポレイテッド | 2部分調節性眼内レンズデバイス |
| US10004596B2 (en) | 2014-07-31 | 2018-06-26 | Lensgen, Inc. | Accommodating intraocular lens device |
| CN107635511A (zh) * | 2015-06-10 | 2018-01-26 | 力景公司 | 人工晶状体材料和组分 |
| CN108778185B (zh) | 2015-12-01 | 2021-04-27 | 雷恩斯根公司 | 调节性人工晶状体装置 |
| CN108359051B (zh) * | 2018-02-09 | 2021-01-05 | 山东金丰新材料科技有限公司 | 高氟含量含氟丙烯酸酯共聚物涂层材料及其制备方法 |
| CN111154025B (zh) * | 2018-11-07 | 2022-04-22 | 上海飞凯材料科技股份有限公司 | 含氟树脂、涂料及制备方法 |
| JP2022531027A (ja) | 2019-05-03 | 2022-07-06 | ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド | 高反応性指数、高アッベ組成物 |
| US11708440B2 (en) | 2019-05-03 | 2023-07-25 | Johnson & Johnson Surgical Vision, Inc. | High refractive index, high Abbe compositions |
| US11795252B2 (en) | 2020-10-29 | 2023-10-24 | Johnson & Johnson Surgical Vision, Inc. | Compositions with high refractive index and Abbe number |
| CN119100406B (zh) * | 2024-09-05 | 2025-06-06 | 星空男孩(杭州)科技有限公司 | 改性二氧化硅气凝胶粉及制备方法、气凝胶浆料及制备方法和应用 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3162676A (en) | 1962-06-18 | 1964-12-22 | Nat Starch Chem Corp | Ethylenically unsaturated derivatives of 2, 4-dihydroxybenzophenone |
| US3299173A (en) | 1963-04-15 | 1967-01-17 | Diamond Alkali Co | Unsaturated polyesters prepared from reactable fire-retardant agents |
| US3950315A (en) * | 1971-06-11 | 1976-04-13 | E. I. Du Pont De Nemours And Company | Contact lens having an optimum combination of properties |
| US4304895A (en) | 1973-06-20 | 1981-12-08 | Wesley-Jessen, Inc. | Ultraviolet absorbing corneal contact lenses |
| US4528311A (en) | 1983-07-11 | 1985-07-09 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles |
| JPS60200223A (ja) * | 1984-03-24 | 1985-10-09 | Toyo Contact Lens Co Ltd | 酸素透過性硬質コンタクトレンズ |
| DE3439483A1 (de) | 1984-10-27 | 1986-05-07 | Röhm GmbH, 6100 Darmstadt | Radikalisch polymerisierbarer uv-absorber, verfahren zu seiner herstellung und seine polymere |
| US4787903A (en) | 1985-07-24 | 1988-11-29 | Grendahl Dennis T | Intraocular lens |
| JPH073517B2 (ja) * | 1985-11-29 | 1995-01-18 | チバ―ガイギー アクチエンゲゼルシャフト | 非含水型ソフトコンタクトレンズおよびその製造方法 |
| US4742140A (en) * | 1986-01-23 | 1988-05-03 | E. I. Du Pont De Nemours And Company | Oil- and water-repellent copolymers |
| EP0243605B1 (en) * | 1986-02-27 | 1993-06-16 | Dainippon Ink And Chemicals, Inc. | Fluorine-containing resin composition having a low refractive index |
| US4716234A (en) | 1986-12-01 | 1987-12-29 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-(2'-hydroxy-5'-acryloyloxyalkoxyphenyl)-2H-benzotriazole |
| US4795793A (en) * | 1986-12-05 | 1989-01-03 | Daikin Industries Ltd. | Fluorine-containing copolymer and oil and water repellent composition containing the same |
| US4816031A (en) | 1988-01-29 | 1989-03-28 | Pfoff David S | Intraocular lens system |
| US4932966A (en) | 1988-08-15 | 1990-06-12 | Storz Instrument Company | Accommodating intraocular lens |
| JPH0329918A (ja) * | 1989-06-27 | 1991-02-07 | Menikon:Kk | 眼用レンズ材料および眼用レンズの製造法 |
| JPH03140918A (ja) * | 1989-10-27 | 1991-06-14 | Seiko Epson Corp | ソフトコンタクトレンズ |
| US5269813A (en) * | 1990-06-12 | 1993-12-14 | Menicon Co., Ltd. | Material for one-piece intraocular lenses |
| US5066301A (en) | 1990-10-09 | 1991-11-19 | Wiley Robert G | Variable focus lens |
| US5443506A (en) | 1992-11-18 | 1995-08-22 | Garabet; Antoine L. | Lens with variable optical properties |
| US5470932A (en) | 1993-10-18 | 1995-11-28 | Alcon Laboratories, Inc. | Polymerizable yellow dyes and their use in opthalmic lenses |
| KR100438477B1 (ko) * | 1997-12-02 | 2004-07-03 | 호야 헬쓰케어 가부시키가이샤 | 안내 렌즈 및 일체형 안내 렌즈의 제조 방법 |
| JPH11249084A (ja) * | 1998-03-06 | 1999-09-17 | Kuraray Co Ltd | 眼用レンズ材料およびその製造方法 |
| US6117171A (en) | 1998-12-23 | 2000-09-12 | Skottun; Bernt Christian | Encapsulated accommodating intraocular lens |
| JP2001066557A (ja) * | 1999-08-25 | 2001-03-16 | Kuraray Co Ltd | ヒドロゲルおよびそれからなる眼用レンズ |
| US6730123B1 (en) | 2000-06-22 | 2004-05-04 | Proteus Vision, Llc | Adjustable intraocular lens |
| US20030060878A1 (en) | 2001-08-31 | 2003-03-27 | Shadduck John H. | Intraocular lens system and method for power adjustment |
| US8048155B2 (en) | 2002-02-02 | 2011-11-01 | Powervision, Inc. | Intraocular implant devices |
| US7261737B2 (en) | 2002-12-12 | 2007-08-28 | Powervision, Inc. | Accommodating intraocular lens system and method |
| WO2004054471A2 (en) | 2002-12-12 | 2004-07-01 | Powervision | Accommodating intraocular lens system and method |
| AU2003297101A1 (en) | 2002-12-12 | 2004-06-30 | Powervision | Lens system for power adjustment using micropumps |
| US7217288B2 (en) | 2002-12-12 | 2007-05-15 | Powervision, Inc. | Accommodating intraocular lens having peripherally actuated deflectable surface and method |
| US7247168B2 (en) | 2002-12-12 | 2007-07-24 | Powervision, Inc. | Accommodating intraocular lens system and method |
| US8361145B2 (en) | 2002-12-12 | 2013-01-29 | Powervision, Inc. | Accommodating intraocular lens system having circumferential haptic support and method |
| DE10346024B4 (de) | 2003-08-26 | 2019-01-17 | Carl Zeiss Meditec Ag | Ciliarmuskel-betätigtes, akkommodationsfähiges Linsenimplantat |
| JP4402691B2 (ja) * | 2004-05-28 | 2010-01-20 | 株式会社メニコン | コンタクトレンズ |
| US7247689B2 (en) | 2004-05-28 | 2007-07-24 | Advanced Medical Optics, Inc. | Biocompatible polymeric compositions for use in making anterior chamber intraocular lenses |
| US8038711B2 (en) | 2005-07-19 | 2011-10-18 | Clarke Gerald P | Accommodating intraocular lens and methods of use |
| US7714039B2 (en) | 2006-07-21 | 2010-05-11 | Alcon, Inc. | Low-tack ophthalmic and otorhinolaryngological device materials |
| TWI399228B (zh) | 2006-07-21 | 2013-06-21 | Alcon Inc | 低黏性的眼科與耳鼻喉科裝置材料(二) |
| EP1905415B1 (de) | 2006-09-27 | 2009-07-01 | Ivoclar Vivadent AG | Polymerisierbare Zusammensetzungen mit Acylgermanium-Verbindungen als Initiatoren |
| US8034106B2 (en) | 2007-02-02 | 2011-10-11 | Adoptics Ag | Interfacial refraction accommodating lens (IRAL) |
| JP5452235B2 (ja) * | 2007-02-21 | 2014-03-26 | パワーヴィジョン・インコーポレーテッド | 眼科用デバイスに適したポリマー材料及びその製造方法 |
| US7753953B1 (en) | 2007-03-30 | 2010-07-13 | Kingman Yee | Accommodating intraocular lens system |
| CN101214392A (zh) * | 2008-01-11 | 2008-07-09 | 北京科技大学 | 一种含有可逆二硫键的注入式人工晶状体材料及制备方法 |
| US8254034B1 (en) | 2008-03-31 | 2012-08-28 | Rhevision Technology, Inc. | Fluidic adaptive lens with a lens membrane having suppressed fluid permeability |
| EP2315559B1 (en) | 2008-07-24 | 2012-01-25 | Nulens Ltd | Accommodating intraocular lens (aiol) capsules |
| TWI453199B (zh) | 2008-11-04 | 2014-09-21 | Alcon Inc | 用於眼用鏡片材料之紫外光/可見光吸收劑 |
| JP5520960B2 (ja) * | 2008-11-11 | 2014-06-11 | ダイキン工業株式会社 | 撥水撥油防汚性組成物の製造方法 |
| CN101475507B (zh) * | 2009-01-20 | 2012-05-23 | 大连理工大学 | 一种含氟丙烯酰胺、制备方法及其共聚物制备 |
| CN101564551B (zh) | 2009-06-05 | 2012-07-25 | 北京科技大学 | 一种丙烯酸酯类形状记忆性人工晶状体材料及制备方法 |
| US8331750B2 (en) * | 2010-02-01 | 2012-12-11 | Enlighting Inc | Optical fibers having a surface light field emulation (s-LiFE) segment and method of making the same |
| CN101845114B (zh) * | 2010-05-28 | 2012-07-18 | 北京化工大学 | 一种含氟丙烯酸酯微乳液的制备方法 |
| CN103013208B (zh) * | 2012-12-31 | 2015-04-15 | 广东工业大学 | 一种水溶性uv固化含氟丙烯酸酯涂料及其制备方法 |
| CN103232567B (zh) * | 2013-04-22 | 2015-10-28 | 南京工业大学 | 一种制备含氟丙烯酸酯或丙烯酸酯共聚物的方法 |
-
2014
- 2014-12-02 ES ES14816036T patent/ES2699994T3/es active Active
- 2014-12-02 PL PL14816036T patent/PL3077429T3/pl unknown
- 2014-12-02 CN CN201480065464.9A patent/CN105793303B/zh not_active Expired - Fee Related
- 2014-12-02 PT PT14816036T patent/PT3077429T/pt unknown
- 2014-12-02 US US14/557,676 patent/US10722612B2/en active Active
- 2014-12-02 DK DK14816036.9T patent/DK3077429T3/da active
- 2014-12-02 JP JP2016536166A patent/JP6224837B2/ja active Active
- 2014-12-02 WO PCT/US2014/068052 patent/WO2015084786A1/en not_active Ceased
- 2014-12-02 CA CA2927620A patent/CA2927620C/en not_active Expired - Fee Related
- 2014-12-02 AU AU2014357332A patent/AU2014357332B2/en not_active Ceased
- 2014-12-02 EP EP14816036.9A patent/EP3077429B1/en active Active
- 2014-12-03 TW TW103142005A patent/TWI639644B/zh not_active IP Right Cessation
- 2014-12-03 AR ARP140104498A patent/AR098601A1/es unknown
-
2020
- 2020-06-18 US US16/904,867 patent/US11213606B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3077429B1 (en) | 2018-09-26 |
| CA2927620C (en) | 2018-03-13 |
| CA2927620A1 (en) | 2015-06-11 |
| EP3077429A1 (en) | 2016-10-12 |
| CN105793303B (zh) | 2017-08-29 |
| CN105793303A (zh) | 2016-07-20 |
| AU2014357332A1 (en) | 2016-05-05 |
| PL3077429T3 (pl) | 2019-02-28 |
| JP6224837B2 (ja) | 2017-11-01 |
| AU2014357332B2 (en) | 2017-12-21 |
| WO2015084786A1 (en) | 2015-06-11 |
| WO2015084786A8 (en) | 2016-01-07 |
| ES2699994T3 (es) | 2019-02-13 |
| US20150151021A1 (en) | 2015-06-04 |
| US10722612B2 (en) | 2020-07-28 |
| JP2016540857A (ja) | 2016-12-28 |
| US11213606B2 (en) | 2022-01-04 |
| TWI639644B (zh) | 2018-11-01 |
| US20200316251A1 (en) | 2020-10-08 |
| PT3077429T (pt) | 2018-12-03 |
| DK3077429T3 (da) | 2019-01-02 |
| AR098601A1 (es) | 2016-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI639644B (zh) | 軟的疏水丙烯酸系材料 | |
| JP6188733B2 (ja) | 改良されたポリマーおよび眼科利用方法 | |
| TWI513768B (zh) | 疏水性丙烯酸系眼內水晶體材料 | |
| JP5363683B2 (ja) | グリスニングが低い、高屈折率の眼科的アクリルデバイス材料 | |
| JP6371480B2 (ja) | 眼科用装具のための低含水率アクリレート−アクリルアミドコポリマー | |
| AU2016220438B2 (en) | Wet-pack intraocular lens materials with high refractive index | |
| EP2225325A2 (en) | High refractive index ophthalmic device materials | |
| JP2021506500A (ja) | 眼科製品のための組成物 | |
| JP6166479B2 (ja) | 高い屈折率および最小限のグリスニングを有する軟質アクリル材料 | |
| JP6392993B2 (ja) | 眼科用装具のための疎水性アクリレート−アクリルアミドコポリマー | |
| JP2023052498A (ja) | 眼適用のためのポリマーおよび方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |